BioScrip (BIOS)
Add to Watchlists Create an AlertBIOS Key Stats
| Income Statement | |
| Revenue TTM | 706.08M |
| Revenue Quarterly YoY Growth | 27.91% |
| EPS Diluted TTM | 1.076 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | 59.28M |
| Profitability | |
| Gross Profit Margin Quarterly | 31.77% |
| Profit Margin Quarterly | -4.08% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 776.74M |
| Enterprise Value | 1.030B |
| PE Ratio TTM | 12.64 |
| PE 10 Pro | Go Pro |
| PEG Ratio | 0.0051 |
| Price / Book Value | 2.702 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.8814 |
| Free Cash Flow | -16.50M |
| Return on Equity | 21.57% |
BIOS News
- BioScrip To Present At Jefferies 2013 Global Healthcare Conference PR Newswire May 23
- Do These Tuesday Upgrades Present a Buying Opportunity? Fool May 23
- Shorts Are Covering 3 Stocks Undervalued By EPS Trends May 21
- Movers roundup: Tesla, BioScrip May 21
- BioScrip rises on positive analyst expectations May 21
- Jefferies Starts BioScrip (BIOS) at Buy, $17 PT Street Insider May 21
- Nasdaq stocks posting largest volume increases May 15
- Prominent Hedge Fund Prescott Group Buying Some Little-Known Plays May 14
- Are You Missing Something Easy at BioScrip? Fool May 14
- Investing In Pharmacy Stocks Could Be The Next Major Play May 13
BIOS Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). BioScrip is up 99.41% over the last year vs S&P 500 Total Return up 28.03%, Echo Therapeutics down 68.21%, and Alimera Sciences up 69.08%.
BIOS Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Cash Flow Statement View Statement
You may also be interested in these BIOS related companies
Pro Ratings for BIOS
Pro Report PDF for BIOS
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download BIOS Pro Report PDF
Pro Strategies Featuring BIOS
Did BioScrip make it into our Pro Portfolio Strategies?
BIOS Profile
Sector: Healthcare
Industry: Drug Manufacturers - Major
Other BIOS Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BIOS | 13.60 | -0.06 | -0.44% | 776.74M |
